Severe ketoacidosis in a patient taking an SGLT2 inhibitor for diabetes.

Kristine Vaage Hatlen, Archana Sharma, Ingrid Nermoen

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 2020 Sep 08

filter terms:

Diabetic ketoacidosis is rarely seen in patients with type 2 diabetes. Doctors and patients need to be aware that sodium-glucose cotransporter 2 (SGLT2) inhibitors increase the risk of diabetic ketoacidosis, also in patients with type 2 diabetes. Here we present the case of a woman in her forties hospitalised with severe diabetic ketoacidosis while undergoing treatment for a presumed type 2 diabetes.

Citation

Kristine Vaage Hatlen, Archana Sharma, Ingrid Nermoen. Severe ketoacidosis in a patient taking an SGLT2 inhibitor for diabetes. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 2020 Sep 08;140(12)